Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia

Blood

Volumn 100, Issue 1, 2002, Pages 67-71

  Davies, Stella M ^a,b,c,d   Bhatia, Smita ^a,b,c,d   Ross, Julie A ^a,b,c,d   Kiffmeyer, William R ^a,b,c,d   Gaynon, Paul S ^a,b,c,d   Radloff, Gretchen A ^a,b,c,d   Robison, Leslie L ^a,b,c,d   Perentesis, John P ^a,b,c,d  

^a CHILDREN S ONCOLOGY GROUP   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFANT; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0036660410     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V100.1.67     Document Type: Article

References (21)

1. Salinas AE, Wong MG. Glutathione S-transferases: a review. Curr Med Chem. 1999;6:279-309.
2. Tsuchida S, Sato K. Glutathione transferases and cancer. Crit Rev Biochem Mol Biol. 1992;27:337-384.
3. Seidegard J, Vorachek WR, Pero RW, Pearson WR. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci U S A. 1988;85:7293-7297.
4. Pemble S, Schroeder KR, Spencer SR, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J. 1994;300:271-276.
5. Chen CL, Liu Q, Pui CH, et al. Higher frequency of glutathione S-transferase deletions in black children with acute lymphoblastic leukemia. Blood. 1997;89:1701-1707.
6. Krajinovic M, Labuda D, Richer C, Karimi S, Sinnett D. Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood. 1999;93:1496-1501.
7. Stanulla M, Schrappe M, Brechlin AM, Zimmermann M, Welte K. Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study. Blood. 2000;95:1222-1228.
8. Nachman J, Sather HN, Cherlow JM, et al. Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group. J Clin Oncol. 1998;16:920-930.
9. Nachman JB, Sather HN, Sensel MG, et al. Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy [comment appears in N Engl J Med. 1998;339:1080-1081]. N Engl J Med. 1998;338:1663-1671.
10. Reaman GH, Sposto R, Sensel MG, et al. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group [comment appears in J Clin Oncol. 1999;17:438-440.]. J Clin Oncol. 1999;17:445-455.
11. Steinherz PG, Siegel SE, Bleyer WA, et al. Lymphomatous presentation of childhood acute lymphoblastic leukemia: a subgroup at high risk of early treatment failure. Cancer. 1991;68:751-758.
12. Uckun FM, Nachman JB, Sather HN, et al. Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children's Cancer Group. Cancer. 1998;83:2030-2039.
13. Ross JA, Severson RK, Pollock BH, Robison LL. Childhood cancer in the United States: a geographical analysis of cases from the Pediatric Cooperative Clinical Trials groups. Cancer. 1996;77: 201-207.
14. Chen CL, Liu Q, Relling MV. Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics. 1996;6:187-191.
15. Boyle EB, Steinbuch M, Tekautz T, Gutman JR, Robison LL, Perentesis JP. Accuracy of DNA amplification from archival hematological slides for use in genetic biomarker studies. Cancer Epidemiol Biomarkers Prev. 1998;7:1127-1131.
16. Davies SM, Robison LL, Buckley JD, Radloff GA, Ross JA, Perentesis JP. Glutathione S-transferase polymorphisms in children with myeloid leukemia: a Children's Cancer Group study. Cancer Epidemiol Biomarkers Prev. 2000;9:563-566.
17. Shi MM, Myrand SP, Bleavins MR, de la Iglesia FA. High-throughput genotyping method for glutathione S-transferase T1 and M1 gene deletions using TaqMan probes. Res Commun Mol Pathol Pharmacol. 1999;103:3-15.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
19. Peto R, Peto J. Asymptomatically efficient rank in variant text procedures. J R Stat Soc (A). 1972;135:185.
20. Rollinson S, Roddam P, Kane E, et al. Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukemia. Carcinogenesis. 2000;21:43-47.
21. Perentesis JP, Why is age such an important independent prognostic factor in acute lymphoblastic leukemia? Leukemia. 1997;11(suppl 4):4-7.